This study aims to evaluate the cost-utility of the routine offers of HIV counseling and testing in community hospitals compared with the current practice. It analyses this by using the social perspective and the payer prospective. The model-based economic evaluation was use to analyze this. Data about the quality of life of HIV infected patients a

The scientific information to support the causal relationship between input/output and outcome/impact of HIV prevention is inadequate and fragmented. A properly conducted economic evaluation could present reasoned and justifiable arguments as to why more or fewer resources should be directed towards particular HIV prevention interventions. However,

The objective of this study is to estimate the cost-utility analysis of the cholinesterase inhibitors (i.e., donepezil, galantamine and rivastigmine) compared with no drug treatment in patients with mild to moderate alzheimer’s disease (AD) in Thailand based on the societal and governmental perspectives and to estimate the budget impact of the ch

A cost-utility analysis was performed to estimate the costs and quality adjusted life year (QALY) of HIV prevention program compared to only existing programs. This analysis focused on both the general population and high risk populations. This study found that the incremental cost effectiveness ratio of HIV vaccination was most sensitive to change

A substance in human breast milk seems to reduce the risk of mother-to-child transmission of H.I.V., scientists have reported.Researchers working in Zambia collected breast milk samples from 81 H.I.V.-positive women who transmitted the virus to their infants during breast-feeding, 86 H.I.V.-positive

More than 200 researchers investigating colon cancer tumors have found genetic vulnerabilities that could lead to powerful new treatments. The hope is that drugs designed to strike these weak spots will eventually stop a cancer that is now almost inevitably fatal once it has spread.Scientists increa

WASHINGTON — It would seem a business executive’s dream: legally pay a competitor to keep its product off the market for years.Congress has failed to stop it, and for more than a decade generic drug makers and big-name pharmaceutical companies have been winning court rulings that allowed it.Until th

The settlement is part of a broad crackdown on bribery by multinational companies in foreign countries that has hit several of the world’s biggest pharmaceutical companies.Pfizer in 2004 became the first pharmaceutical company to volunteer information about past wrongdoing to the Justice Department,

The objective of this study is to determine the economic evaluation of the treatment of chronic hepatitis B by using drugs that are currently available in Thailand, and to analyze the budget impact in listing drugs with cleared health economic evaluation into the National List of Essential Medicines.  01-340-2552

Drug-resistant HIV has been increasing in parts of sub-Saharan Africa over the last decade, according to experts writing in the Lancet.Studies on 26,000 untreated HIV-positive people in developing countries were reviewed by the team.They said resistance could build up if people fail to stick to drug